By combining AI, molecular dynamics, quantum calculation, and network theory, PharmCADD's platform enables scientists to quickly and accurately search for specific drug candidates in a vast chemical space. Their in-silico drug design platform helps overcome challenges in the drug discovery process by using protein folding algorithms and predictive modeling to design and synthesize new drug candidates. PharmCADD is focused on developing drugs for various diseases including cancer, Alzheimer's, and COVID-19.